* Theratechnologies-Abstract submitted by its partner, Taimed Biologics, for 24-week study of Ibalizumab phase III study has been selected for late breaker presentation Source text for Eikon: Further company coverage: NEW YORK, Jan 17 Dozens of protesters gathered outside of Goldman Sachs Group Inc headquarters on Tuesday to rally against President-elect Donald Trump’s picking several former executives of the Wall Street bank for top jobs in his administration.